Loading chart…
PRE-MARKET
Molbio Diagnostics Limited, a point-of-care diagnostics company, provides healthcare technologies to diagnose infectious and non-communicable diseases. It manufactures and sells chip based diagnostic devices, chips and reagents, X-ray equipment's, and single/dual detectors. It also offers disposable POCT devices, which includes dengue, malaria, and COVID-19 tests; Tabletop analysers, a portable machine that are used to perform molecular or immunodiagnostic tests to detect infectious diseases, such as tuberculosis, human papillomavrus, STIs, and GI disorders.
Molbio Diagnostics Limited (MOLBIO) is listed on the NSE in the Healthcare sector, Medical Devices industry. The MOLBIO share price is ₹1,360.20 (-2.98% today), with a market capitalisation of ₹157B and a price-to-earnings (P/E) ratio of 94.1. MarketRipple tracks the MOLBIO investment thesis, the ripple-chain impact of market events on Molbio Diagnostics Limited, and the Healthcare sector outlook.
Open
₹1,350.60
High
₹1,406.00
Low
₹1,342.20
Prev. Close
₹1,402.00
52W High
₹1,686.80
52W Low
₹926.35
Day range
₹1,342.20–₹1,406.00
52-week range
₹926.35–₹1,686.80
Volume
114K
P/E
94.1
ROE
14.2%
D/E
0.38
Margin
10.8%
Molbio Diagnostics Limited (NSE: MOLBIO) is currently trading at ₹1,360.20 (-2.98%).
Molbio Diagnostics Limited's market capitalization is ₹157B.
Molbio Diagnostics Limited's price-to-earnings (P/E) ratio is 94.1.
Molbio Diagnostics Limited operates in the Healthcare sector (Medical Devices).
Analyst consensus on Molbio Diagnostics Limited currently reads strongly positive, based on 3 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.